Navigation Links
BioStorage Technologies Serves as Repository for Landmark Study of Coronary Artery Disease
Date:7/23/2008

INDIANAPOLIS, July 23 /PRNewswire/ -- BioStorage Technologies, Inc. (BST) will serve as the biorepository partner for the first phase of the Indiana Health Study, a new landmark longitudinal study of coronary artery disease. This community-based research initiative will utilize the population of Indianapolis and surrounding areas as study participants and will enable research that will lead to new drugs and diagnostics that allow doctors to better manage common, chronic diseases such as heart disease, cancer and diabetes.

Sponsored by the Fairbanks Institute for Healthy Communities, an Indianapolis-based nonprofit organization, the Indiana Health Study will create one of the nation's most comprehensive resources for academic and commercial research by integrating biological samples, medical data and lifestyle information collected from two cohorts of people: patients with coronary artery disease and people without the disease.

The collected biological samples will be stored at BST's state-of-the-art facility located in Indianapolis. "We selected BioStorage because of their expertise in cold chain logistics, sample management and long term storage, which are all necessities for a study of this scope and importance," said Dr. Cynthia Helphingstine, president and COO of the Fairbanks Institute. "We are fortunate to have partnered with a company that shares our strong commitment for community-based life science research."

Dr. John F. Mills, M.D., Ph.D., chief executive officer of BioStorage Technologies believes the Indiana Health Study can make a significant impact on the future of health care for people in Indiana and around the world. "We believe we can play a vital role in advancing health care and research initiatives through ensuring sample integrity. In a study of this magnitude samples are vital and could possibly hold the key to unlocking the causes of some of this nation's deadliest diseases."

While the Indiana Health Study will follow participants for years, Helphingstine anticipates immediate benefits as well. Samples will be available for researchers as soon as they are collected. The Fairbanks Institute intends to study multiple chronic diseases with future research platforms including studies on cancer, diabetes and central nervous system disorders.

About BioStorage Technologies, Inc.:

BioStorage Technologies, Inc. is a leader in sample storage, inventory management and coldchain logistics for the biotechnology and pharmaceutical industries. The company offers secure, temperature-controlled storage; real-time tracking of stored biological samples; and next-day return of biomaterials. BioStorage Technologies is privately-held and headquartered in Indianapolis with an additional full-service site near Frankfurt, Germany. For more information, visit http://www.biostorage.com or call +1 (866) 697-2675 or +49-6155-898-1010.

About Fairbanks Institute

Formed with a $10 million gift from the Richard M. Fairbanks Foundation and the collaboration of BioCrossroads, Indiana University School of Medicine, Regenstrief Institute and other Indianapolis community health leaders, Fairbanks Institute is creating one of the nation's most comprehensive resources for finding better ways to prevent, diagnose and treat the nation's most common, chronic diseases.

Press Contact:

Whitney Dean

Miller Brooks, Inc.

317-873-8100

whitney@millerbrooks.com


'/>"/>
SOURCE BioStorage Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioStorage Technologies Announces Platinum Sponsorship of Biorepositories 2008
2. BioStorage Technologies Forms Scientific Advisory Board with Leading Life Science Experts
3. BioStorage Technologies Appoints Dr. Wolfgang Hoffer as Managing Director of European Operations
4. BioStorage Technologies Appoints Lori Ball as Vice President
5. BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy
6. Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offering Period
7. MacroGenics Acquires Raven Biotechnologies
8. Netsmart Technologies Web Seminar Helps Behavioral Health Organizations Understand Electronic Prescribing and the Importance of New Medicare-Related E-Prescribing Legislation
9. FDA Grants Epeius Biotechnologies Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas
10. Epeius Biotechnologies Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteosarcoma
11. Senesco Technologies Closes Remaining $3.0 Million of Previously Announced Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... RESEARCH TRIANGLE PARK, N.C. , April ... UTHR ) today announced that its Board of ... of the company,s common stock. This program will became ... 2017. Purchases may be made in the open market, ... time to time as determined by United Therapeutics, management ...
(Date:4/27/2017)... ... , ... Mitotech S.A, a Luxembourg based clinical stage biotechnology company, announced positive ... a rare devastating genetic disease that leads to a sudden and rapid loss of ... patients carrying 11778, 14484 and 3460 mutations and having experienced the onset of symptoms ...
(Date:4/27/2017)... ... April 27, 2017 , ... During the ... review how testing for 1,25-Dihydroxyvitamin D can enhance clinical practice. Participants will learn ... 1,25 dihydroxyvitamin D. , Dr. Gregory Plotnikoff, senior consultant with Minnesota Personalized Medicine, ...
(Date:4/27/2017)... USA (PRWEB) , ... April 27, 2017 , ... ... optics and photonics , joined other scientists, researchers, engineers, and industry professionals in ... to strengthen America's ability to compete in the world photonics industry. , This ...
Breaking Biology Technology:
(Date:4/11/2017)... April 11, 2017 NXT-ID, Inc. (NASDAQ: ... company, announces the appointment of independent Directors Mr. Robin ... its Board of Directors, furthering the company,s corporate governance and ... Gino Pereira ... look forward to their guidance and benefiting from their considerable ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
(Date:4/5/2017)... KEY FINDINGS The global market for stem ... 25.76% during the forecast period of 2017-2025. The rise ... growth of the stem cell market. Download ... The global stem cell market is segmented on the ... cell market of the product is segmented into adult ...
Breaking Biology News(10 mins):